Newsletter | August 26, 2024

08.26.24 -- Bacterial Endotoxin Testing, Part 1: Overview

FEATURED EDITORIAL

Bacterial Endotoxin Testing, Part 1: Overview

All injectable drug products and implantable medical devices that come into contact with the bloodstream or spinal fluid are tested for endotoxins. This article provides an overview of bacterial endotoxin testing and the LAL method.

INDUSTRY INSIGHTS

Designing Delivery Devices For Older Adults With Cognitive Impairment

Leverage our insights to improve your human factors studies and ensure the effective inclusion of older adults with mild cognitive impairment.

Switching From Vials To PFS And IV To Subcutaneous Formulations

Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.

Applying Automation To The Manufacture Of Drug Delivery Devices

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Nanoforming: The Patient- And Planet-Centric Approach

By reducing the size of drug particles, nanoforming can open up new opportunities – from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits.

PBPK Modeling: Mitigating Absorption Risks In Early Drug Development

Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.

Autoinjectors: A Revolutionary Leap In Drug Delivery

Explore how the widespread adoption of autoinjectors is transforming the biopharmaceutical industry's approach to drug delivery, offering precise dosing, patient adherence, and safety.

SOLUTIONS

Proven Vial Containment That Scales From R&D To Commercial

Pathways For Pulmonary Delivery

Medical Device Risk Management